| 351 |
10926309 | Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus. | 2000 |
1 |
| 352 |
11110228 | Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. | 2000 Oct |
1 |
| 353 |
11965830 | Prevention of type 2 diabetes. | 2000 Oct |
1 |
| 354 |
10226869 | PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. | 1999 May |
1 |
| 355 |
10400405 | Rosiglitazone. | 1999 Jun |
5 |
| 356 |
10480188 | [Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs]. | 1999 Aug |
1 |
| 357 |
10577070 | [Type II diabetes mellitus. Rosiglitazone is effective against insulin resistance]. | 1999 Sep |
1 |
| 358 |
10605995 | Oral pharmacologic management of type 2 diabetes. | 1999 Dec |
1 |
| 359 |
11139821 | Rosiglitazone: a new therapy for Type 2 diabetes. | 1999 Oct |
1 |
| 360 |
11220287 | Promising new approaches. | 1999 May |
1 |
| 361 |
11220295 | Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study. | 1999 May |
1 |
| 362 |
9454824 | Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. | 1998 Feb |
1 |